• Top
  • About
  • Organization and Members
  • Group of Metabolomics
  • Group of Metabolomics

    Molecules found in blood or urine whose concentrations vary within or among individuals, reflecting disease risks of the subjects, are called disease biomarkers. Measurement of such biomarkers can provide valuable information for disease prevention and early diagnosis.
    The Group of Metabolomics aims to develop the Omics database for discovering useful biomarkers through the global identification and quantification (i.e. multi-omics studies) of proteins and small compounds found in blood or urine specimens. Such multi-omics studies can contribute to advancement of personalized prevention and treatment of diseases, as well as identification of disease mechanisms and development of novel therapeutics.

    Seizo Koshiba, Professor

    Group Leader
    See details >

    Eiji Hishinuma, Assistant Professor

    Deputy Group Leader
    See details >


    Related Link

    Omics Analysis